Birchview Capital as of March 31, 2023
Portfolio Holdings for Birchview Capital
Birchview Capital holds 55 positions in its portfolio as reported in the March 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Bristol Myers Squibb (BMY) | 39.5 | $51M | 729k | 69.31 | |
| Biodesix (BDSX) | 7.3 | $9.4M | 5.0M | 1.86 | |
| Neurocrine Biosciences (NBIX) | 6.7 | $8.5M | 84k | 101.22 | |
| Prothena Corp SHS (PRTA) | 4.9 | $6.2M | 128k | 48.47 | |
| Quidel Corporation | 4.3 | $5.5M | 61k | 89.09 | |
| ACADIA Pharmaceuticals (ACAD) | 3.7 | $4.7M | 249k | 18.82 | |
| Harrow Health (HROW) | 3.0 | $3.8M | 180k | 21.16 | |
| United Therapeutics Corporation (UTHR) | 2.6 | $3.4M | 15k | 223.93 | |
| Encana Corporation (OVV) | 2.4 | $3.0M | 84k | 36.08 | |
| Masimo Corporation (MASI) | 2.2 | $2.8M | 15k | 184.56 | |
| Phreesia (PHR) | 2.1 | $2.7M | 83k | 32.29 | |
| Aziyo Biologics (ELUT) | 2.0 | $2.5M | 1.7M | 1.51 | |
| Foghorn Therapeutics (FHTX) | 1.3 | $1.6M | 265k | 6.20 | |
| Accelr8 Technology | 1.2 | $1.6M | 2.3M | 0.70 | |
| Alkermes SHS (ALKS) | 1.1 | $1.4M | 50k | 28.20 | |
| Inhibrx | 1.0 | $1.3M | 70k | 18.86 | |
| Alphatec Holdings (ATEC) | 1.0 | $1.2M | 80k | 15.60 | |
| Karyopharm Therapeutics (KPTI) | 0.9 | $1.1M | 291k | 3.89 | |
| Corcept Therapeutics Incorporated (CORT) | 0.8 | $1.1M | 50k | 21.66 | |
| Docgo (DCGO) | 0.7 | $952k | 110k | 8.65 | |
| Ventyx Biosciences (VTYX) | 0.7 | $884k | 26k | 33.48 | |
| Cytokinetics (CYTK) | 0.7 | $880k | 25k | 35.20 | |
| Protagonist Therapeutics (PTGX) | 0.7 | $874k | 38k | 23.00 | |
| Apellis Pharmaceuticals (APLS) | 0.6 | $792k | 12k | 66.00 | |
| Pioneer Natural Resources | 0.6 | $776k | 3.8k | 204.21 | |
| Equitrans Midstream Corp (ETRN) | 0.6 | $769k | 133k | 5.78 | |
| Travere Therapeutics (TVTX) | 0.5 | $675k | 30k | 22.50 | |
| Bluebird Bio (BLUE) | 0.5 | $633k | 199k | 3.18 | |
| 2seventy Bio (TSVT) | 0.5 | $610k | 60k | 10.20 | |
| Iveric Bio | 0.5 | $608k | 25k | 24.32 | |
| ImmunoGen | 0.5 | $576k | 150k | 3.84 | |
| 10x Genomics Cl A Com (TXG) | 0.4 | $558k | 10k | 55.80 | |
| Soleno Therapeutics | 0.4 | $525k | 245k | 2.14 | |
| Arvinas Ord (ARVN) | 0.3 | $410k | 15k | 27.33 | |
| Silk Road Medical Inc Common | 0.3 | $391k | 10k | 39.10 | |
| Halozyme Therapeutics (HALO) | 0.3 | $382k | 10k | 38.20 | |
| Xenon Pharmaceuticals (XENE) | 0.3 | $358k | 10k | 35.80 | |
| Chinook Therapeutics | 0.3 | $347k | 15k | 23.13 | |
| Sarepta Therapeutics (SRPT) | 0.3 | $345k | 2.5k | 138.00 | |
| Xencor (XNCR) | 0.3 | $343k | 12k | 27.89 | |
| Kiniksa Pharmaceuticals | 0.3 | $323k | 30k | 10.77 | |
| Kalvista Pharmaceuticals (KALV) | 0.2 | $314k | 40k | 7.85 | |
| Amicus Therapeutics (FOLD) | 0.2 | $311k | 28k | 11.11 | |
| Keros Therapeutics (KROS) | 0.2 | $299k | 7.0k | 42.71 | |
| Progyny (PGNY) | 0.2 | $289k | 9.0k | 32.11 | |
| Cullinan Oncology (CGEM) | 0.2 | $257k | 25k | 10.23 | |
| BioCryst Pharmaceuticals (BCRX) | 0.1 | $167k | 20k | 8.35 | |
| Inflarx Nv (IFRX) | 0.1 | $136k | 70k | 1.94 | |
| Gossamer Bio (GOSS) | 0.1 | $125k | 99k | 1.26 | |
| Stoke Therapeutics (STOK) | 0.1 | $125k | 15k | 8.33 | |
| G1 Therapeutics | 0.1 | $107k | 40k | 2.67 | |
| Nektar Therapeutics (NKTR) | 0.1 | $83k | 118k | 0.70 | |
| Yield10 Bioscience | 0.0 | $52k | 19k | 2.77 | |
| Angion Biomedica Corp | 0.0 | $32k | 54k | 0.59 | |
| Aspira Womens Health | 0.0 | $22k | 60k | 0.37 |
